Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
22 10 2020
Historique:
pubmed: 8 10 2020
medline: 29 12 2020
entrez: 7 10 2020
Statut: ppublish

Résumé

Hetero-bifunctional PROteolysis TArgeting Chimeras (PROTACs) represent a new emerging class of small molecules designed to induce polyubiquitylation and proteasomal-dependent degradation of a target protein. Despite the increasing number of publications about the synthesis, biological evaluation, and mechanism of action of PROTACs, the characterization of the pharmacokinetic properties of this class of compounds is still minimal. Here, we report a study on the metabolism of a series of 40 PROTACs in cryopreserved human hepatocytes at multiple time points. Our results indicated that the metabolism of PROTACs could not be predicted from that of their constituent ligands. Their linkers' chemical nature and length resulted in playing a major role in the PROTACs' liability. A subset of compounds was also tested for metabolism by human cytochrome P450 3A4 (CYP3A4) and human aldehyde oxidase (

Identifiants

pubmed: 33026811
doi: 10.1021/acs.jmedchem.0c00793
pmc: PMC8015227
doi:

Substances chimiques

Antineoplastic Agents 0
Small Molecule Libraries 0
Cytochrome P-450 CYP3A EC 1.14.14.1
CYP3A4 protein, human EC 1.14.14.55
Aldehyde Oxidase EC 1.2.3.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11615-11638

Références

J Med Chem. 2018 Jan 25;61(2):462-481
pubmed: 28339196
Eur J Cancer. 2002 May;38(8):1072-80
pubmed: 12008195
Mol Cell. 2017 Jul 6;67(1):5-18.e19
pubmed: 28673542
Biochemistry. 2020 Jan 28;59(3):240-249
pubmed: 31661257
Bioanalysis. 2017 Apr;9(7):541-552
pubmed: 28339283
J Med Chem. 2008 Oct 23;51(20):6581-91
pubmed: 18800822
J Med Chem. 2018 Jan 11;61(1):360-371
pubmed: 29240409
J Biol Chem. 2020 Apr 17;295(16):5377-5389
pubmed: 32144208
Angew Chem Int Ed Engl. 2020 Aug 10;59(33):13865-13870
pubmed: 32415712
J Biomol Screen. 2006 Feb;11(1):40-7
pubmed: 16234336
J Med Chem. 2019 Dec 26;62(24):10955-10994
pubmed: 31385704
J Med Chem. 2016 Oct 13;59(19):8712-8756
pubmed: 27299736
Medchemcomm. 2019 Aug 12;10(10):1755-1764
pubmed: 31867093
Chem Commun (Camb). 2019 Feb 5;55(12):1821-1824
pubmed: 30672516
ACS Chem Biol. 2019 May 17;14(5):882-892
pubmed: 30978004
Pharmacogenomics J. 2011 Feb;11(1):15-24
pubmed: 20177421
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
Drug Discov Today Technol. 2013 Spring;10(1):e199-205
pubmed: 24050248
Arch Toxicol. 2016 Apr;90(4):753-80
pubmed: 26920149
Drug Discov Today Technol. 2019 Apr;31:53-60
pubmed: 31200860
Drug Discov Today Technol. 2019 Apr;31:5-13
pubmed: 31200859
Acta Pharm Sin B. 2018 Sep;8(5):721-732
pubmed: 30245961
Front Chem. 2019 Dec 10;7:849
pubmed: 31921772
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):7124-9
pubmed: 27274052
J Med Chem. 2010 Dec 23;53(24):8441-60
pubmed: 20853847
Nat Commun. 2017 Oct 10;8(1):830
pubmed: 29018234
Curr Opin Chem Biol. 2019 Jun;50:111-119
pubmed: 31004963
Drug Metab Dispos. 2011 Nov;39(11):2066-75
pubmed: 21832003
Chem Res Toxicol. 2002 Mar;15(3):269-99
pubmed: 11896674
Nat Commun. 2019 Jan 10;10(1):131
pubmed: 30631068
Pharmacol Ther. 2017 Jun;174:138-144
pubmed: 28223226
Expert Opin Drug Discov. 2019 Dec;14(12):1313-1327
pubmed: 31538500
J Biol Chem. 2019 May 17;294(20):8015-8022
pubmed: 30926609
Cell Chem Biol. 2020 Jan 16;27(1):19-31.e6
pubmed: 31883964
Methods Mol Biol. 2014;1113:167-86
pubmed: 24523113
Pharmaceuticals (Basel). 2020 Apr 21;13(4):
pubmed: 32326273
Drug Metab Dispos. 2018 Nov;46(11):1556-1561
pubmed: 30333205
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Future Med Chem. 2012 Oct;4(15):1907-32
pubmed: 23088273
Drug Discov Today Technol. 2019 Apr;31:69-80
pubmed: 31200862
J Pharm Sci. 2016 Feb;105(2):460-475
pubmed: 26869412
Xenobiotica. 1988 Aug;18(8):949-54
pubmed: 3188574
J Med Chem. 2011 Jan 27;54(2):635-54
pubmed: 21174434
Semin Cancer Biol. 2020 Dec;67(Pt 2):171-179
pubmed: 32058059
Curr Drug Metab. 2006 Aug;7(6):677-85
pubmed: 16918319
Rapid Commun Mass Spectrom. 2016 Jan 30;30(2):301-10
pubmed: 26689160
Medchemcomm. 2019 May 28;10(6):1037-1041
pubmed: 31304001
Eur J Drug Metab Pharmacokinet. 2014 Jun;39(2):139-46
pubmed: 23797843
J Med Chem. 2017 Feb 23;60(4):1262-1271
pubmed: 28001384
J Med Chem. 2005 Nov 3;48(22):6970-9
pubmed: 16250655
Curr Drug Metab. 2007 Dec;8(8):822-9
pubmed: 18220563
Drug Metab Dispos. 2012 Jul;40(7):1441-8
pubmed: 22522748
Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1147-1158
pubmed: 28988506
Chem Sci. 2020 Mar 4;11(13):3474-3486
pubmed: 33133483
Nature. 2010 Dec 23;468(7327):1067-73
pubmed: 20871596
Drug Metab Dispos. 2012 Sep;40(9):1668-76
pubmed: 22621803
Mol Cell. 2019 Dec 5;76(5):797-810.e10
pubmed: 31606272
ACS Chem Biol. 2015 Aug 21;10(8):1770-7
pubmed: 26035625
J Med Chem. 2018 Jan 25;61(2):543-575
pubmed: 28594553
Rapid Commun Mass Spectrom. 2010 Nov 15;24(21):3127-38
pubmed: 20941759
Bioinformatics. 2019 Feb 15;35(4):650-655
pubmed: 30052776
Mol Pharm. 2016 Jun 6;13(6):1763-78
pubmed: 26926043
Acta Pharm Sin B. 2020 Feb;10(2):207-238
pubmed: 32082969
Mol Cell. 2020 Feb 6;77(3):446-460
pubmed: 32004468
J Med Chem. 2018 Jan 25;61(2):453-461
pubmed: 28378579
Drug Metab Dispos. 2015 Jun;43(6):908-15
pubmed: 25845827
Toxicology. 1995 Dec 15;104(1-3):1-8
pubmed: 8560487
Bioorg Med Chem Lett. 2003 Nov 3;13(21):3783-7
pubmed: 14552779
J Med Chem. 2019 Jan 24;62(2):941-964
pubmed: 30629437
J Med Chem. 2019 Jan 24;62(2):699-726
pubmed: 30540463
Curr Top Med Chem. 2019;19(20):1784-1788
pubmed: 31644408
Cell Chem Biol. 2019 Feb 21;26(2):300-306.e9
pubmed: 30595531
Drug Discov Today Technol. 2013 Spring;10(1):e155-65
pubmed: 24050245
Pharmacol Rep. 2006 Jul-Aug;58(4):453-72
pubmed: 16963792
Anal Bioanal Chem. 2014 Jun;406(15):3621-36
pubmed: 24804821
Cell. 2020 Apr 2;181(1):102-114
pubmed: 31955850
Chem Biol. 2015 Jun 18;22(6):755-63
pubmed: 26051217
ACS Med Chem Lett. 2013 Feb 18;4(4):402-7
pubmed: 24900684
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):E3178-E3187
pubmed: 28373537
Rapid Commun Mass Spectrom. 2020 Jun 30;34(12):e8792
pubmed: 32208529
Angew Chem Int Ed Engl. 2020 Jan 20;59(4):1727-1734
pubmed: 31746102
Science. 2015 Jun 19;348(6241):1376-81
pubmed: 25999370
Expert Opin Drug Discov. 2019 Dec;14(12):1255-1268
pubmed: 31538491
J Med Chem. 2014 Aug 14;57(15):6458-67
pubmed: 25062331
Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):153-68
pubmed: 23231678

Auteurs

Laura Goracci (L)

Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.

Jenny Desantis (J)

Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.

Aurora Valeri (A)

Molecular Horizon, srl, Bettona 06084, Italy.

Beatrice Castellani (B)

Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.

Michela Eleuteri (M)

Montelino Therapeutics, LLC, 7 Powdermill Lane, Southborough, Massachusetts 01772 Unites States.

Gabriele Cruciani (G)

Department of Chemistry, Biology and Biotechnology, University of Perugia, 06123 Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH